Samsung Bioepis sues Fresenius Kabi over patent for generic Humira
Intellectual Property 2022-08-04 11:12 pm By Sam Matthews | Melbourne

Save(0) Please login to bookmark Username or Email Address Password Remember Me Samsung Bioepis Australia has sued fellow biotechnology company Fresenius Kabi over a biosimilar […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.